The approval of novel orphan drug designations continues to grow, while many existing rare disease therapies are receiving approval for expanded indications.…


Ackman's demands may have irked Zoetis, but they bore earnings fruit in Q4

Zoetis beats Q3 earnings forecasts with strong growth in companion-animal sales

Startups pitch health-monitoring ear tags as cost-savers for cow producers

Advanced Animal teams with Zoetis to bring mastitis test to Europe

Love of pets drives animal health on Wall Street: Report

How Zoetis is quietly building its presence in animal diagnostics

Zoetis boosts 2016 forecast on better-than-expected Q2 results

Pershing Square activist Ackman slashes Zoetis holdings